Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Chlormethine Gel Reshapes the Tumour Microenvironment in Mycosis Fungoides
9
Mins
March 2026
Cutaneous T cell lymphomas (CTCL) are a heterogenous group of rare malignancies primarily involving the skin, of which mycosis fungoides…
Read more
17 Nov 2014
Management of Patients with High-Grade Glioma
The scientific basis for the surgical management of patients with glioma is rapidly evolving. The infiltrative nature of these cancers precludes a…
17 Nov 2014
State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the…
4
Mins
17 Oct 2014
Zydelig® (idelalisib): The Force to Fight CLL and FL
After the European Commission granted the marketing authorisation for Gilead’s Zydelig® (idelalisib), a first-in-class oral treatment for chronic…
2
Mins
12 Feb 2014
Cracking the Cancer-Code
The world of medicine and science changed forever the day scientists Watson and Crick discovered the structure of the double helix of DNA, which underpins..
1 Nov 2013
Evidence-Based Treatment Planning in mCRC: The Key to Maximising Outcomes
This Roche sponsored satellite symposium was held as part of the European Cancer Congress 2013, and reviewed the current evidence available on treatment…
1 Nov 2013
The Future of Chronic Lymphocytic Leukaemia Treatment: Balancing Efficacy, Safety and Cost
A Review of the Mundipharma International Ltd Organised Symposium, at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Cologne…
1 Nov 2013
Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer
An emerging body of data suggests that hypofractionated radiation schedules, where a higher dose per fraction is delivered in a smaller number of…
1 Nov 2013
Prostate Cancer and Inflammation: The Role of miRNAs
Approximately 15-20% of all human cancers are assumed to be a result of infection and chronic inflammation due to a constant supply of cytokines and…
Loading posts...
« Previous
1
…
28
29
30
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View